The Latest Breaking News from ISRG

Both Abbott Laboratories and Intuitive Surgical report fourth-quarter results in late January—and both companies offer investors multiple reasons to be bullish.

Intuitive Surgical is set to release its fourth-quarter results next month, and analysts are forecasting a modest, single-digit decline in earnings.

While tariffs were once the bane of their existence, General Motors, Apple, and Intuitive Surgical have come roaring back from "Liberation Day"-induced lows.

Intuitive Surgical (NASDAQ:ISRG) reported revenue of $2.51 billion for the third quarter, up 23% year-over-year, beating analyst estimates of $2.40 billion.

Intuitive Surgical is well-positioned to grow robustly in the upcoming years as device placement and penetration drive results.

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) rose sharply in pre-market trading after the company reported better-than-expected third-quarter financial results.

Major U.S. indexes closed mixed on Tuesday, with the Dow Jones Industrial Average rising nearly 0.5% to 46,924.74, the SP 500 finishing flat at 6,735.35, and the Nasdaq slipping about 0.2% to 22,953.66.These are the top stocks that gained the attention of retail traders and investors through the day: Netflix…

Intuitive Surgical Inc (NASDAQ:ISRG) reported third-quarter financial results Tuesday after the bell. Here’s a rundown of the robotic-assisted surgery company’s report.

Although distressed securities tend to be that way for a reason, certain red-stained stocks are flashing comeback signals—including these three ideas.